晚期结直肠癌在化疗联合艾迪注射液治疗的效果观察

杜芳  王德林  曹玉娟  郝龙英  曹 凤

（北京大学首钢医院，北京，100144）

中图分类号：R969.2    文献标识码：A    文章编号：1674-7860(2015)33-0129-02    证型：IDGB

【摘  要】目的：探讨晚期结直肠癌在化疗联合艾迪注射液治疗的效果。方法：研究我院在2014年6月—2015年6月收治80例直肠癌患者，分为对照组和观察组各40例，其中对照组运用FOLFIRI化疗方案，观察组在对照组基础上添加艾迪注射液辅助治疗，而后分析两组患者在治疗效果上的差异。结果：在治疗有效率上，观察组为47.5%，对照组为35.0%，P＜0.05；在药物不良反应率上，观察组严重程度和发生率要低于对照组，P＜0.05。结论：晚期结直肠癌在化疗联合艾迪注射液治疗可以有效的提升治疗效果，降低药物治疗不良反应。

【关键词】化疗；艾迪注射液；晚期结直肠癌

【Abstract】Objective: To evaluate the effect ofchemotherapy combined with Aidi injection in the treatment of advancedcolorectal cancer. Methods: 80 cases of colorectal cancer admitted to ourhospital from June 2014 to June 2015 divided into control group and observationgroup evenly, the control group received FOLFIRI chemotherapy regimen, and theobservation group received an extra Aidi injection, the differences werecompared and analyzed. Results: The effective rate were 47.5% in observationgroup and 35% in control group respectively, P<0.05; as for the rate of adverse drug reactions, the severityand incidence of observed group were lower than that of control group, P<0.05. Conclusion: chemotherapy withUnited Aidi injection in the treatment of advanced colorectal cancer caneffectively enhance the therapeutic effect and reduce adverse effects of drugs.

【Keywords】Chemotherapy; Aidi injection; Advancedcolorectal cancer

doi:10.3969/j.issn.1674-7860.2015.33.064

请点击此处【在线阅读全文PDF格式】
详情可登录【万方数据】
也可登录【中国知网】